Results 351 to 360 of about 125,579 (360)
Some of the next articles are maybe not open access.
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Nature Reviews Clinical Oncology, 2019Gerasimos P Sykiotis +2 more
exaly
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Nature Reviews Clinical Oncology, 2017Jason J Luke +2 more
exaly
Material design and engineering of next-generation flow-battery technologies
Nature Reviews Materials, 2016Minjoon Park, Jaechan Ryu, Wei Wang
exaly
The immune contexture in cancer prognosis and treatment
Nature Reviews Clinical Oncology, 2017Wolf H Fridman +2 more
exaly
NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN OVARIAN MALIGNANCY
2017openaire +1 more source
Material design for lymph node drug delivery
Nature Reviews Materials, 2019Alex Schudel +2 more
exaly
The gut microbiota — masters of host development and physiology
Nature Reviews Microbiology, 2013Felix Sommer, Fredrik Bäckhed
exaly
The gut microbiota influences anticancer immunosurveillance and general health
Nature Reviews Clinical Oncology, 2018+2 more
exaly
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
Nature Reviews Clinical Oncology, 2016Celine Boutros +2 more
exaly
Neutrophil-to-lymphocyte ratio and platelet-to lymphocyte ratio in polycystic ovary syndrome
2016POLAT, Elif +3 more
openaire +1 more source

